ALK-Abelló (Germany)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Germany), Germany, covering academic research published from 2001 to 2023. Read More.

Open Access Percentage

58%

Total
Publications

Total Open
Publications

Total
Citations

2.9K

Open Access
Percentage

58%

Total
Publications

Total Open
Publications

Total
Citations

2.9K

Wikipedia

Website

download

Breakdown

Publisher Open

30%

Both

15%

Other Platform Open

13%

Closed

42%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 28%

Hybrid 22%

No Guarantees 50%

Other Platform Open

Domain 52%

Institution 26%

Other Internet 22%

Preprint 17%

Public 4%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	12
DOI	Other Internet	6
Europe PMC	Domain	5
Unknown Repository	Other Internet	4
King's College London - Research Portal	Institution	2
bioRxiv	Preprint	2
Utrecht University - Utrecht University Repository	Institution	1
Universitätsbibliothek der Freien Universität Berlin - Refubium	Institution	1
University of Turin - Institutional Research Information System University of Turin	Institution	1
University of the Basque Country - Communities in ADDI	Institution	1

1 / 2

Data updated 7 October 2024